Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.

Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.

Item
http://www.wikidata.org/entity/Q37137165
Current treatment options for local residual nasopharyngeal carcinomaMetronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study.Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment.Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy.Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines.Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge.Nasopharyngeal carcinoma: alternative treatment options after disease progression.Capecitabine for treating head and neck cancer.Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells.Travel warning with capecitabine.Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.
P2860

Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.

Item
http://www.wikidata.org/entity/Q37137165
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
@en
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
@nl
type
label
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
@en
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
@nl
prefLabel
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
@en
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698